Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Journal of Neurology|October 17, 2025
JC virus PCR assay reporting for PML: promises, perils, and pitfallsJagannadha Avasarala, Suhas GangadharaThe American Journal of Emergency Medicine|September 26, 2025
Every minute blinds: Temporal artery ultrasound in the real-time diagnosis of stroke of the eyeJagannadha Avasarala, Suhas Gangadhara, Joseph Bobadilla, et al.Drug Target Insights|July 18, 2018
DRESS Syndrome and Daclizumab Failure-Were Potentially Dangerous Signs Missed in Clinical Trials?Jagannadha AvasaralaF1000Research|May 28, 2016
The TOUCH program and natalizumab: Fundamental flaw in patient protectionJagannadha AvasaralaDrug Target Insights|November 11, 2017
Anti-CD20 Cell Therapies in Multiple Sclerosis-A Fixed Dosing Schedule for Ocrelizumab is OverkillJagannadha AvasaralaInnovations in Clinical Neuroscience|October 6, 2017
It's Time For Combination Therapies: in Multiple SclerosisJagannadha AvasaralaInnovations in Clinical Neuroscience|June 7, 2017
Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment AlgorithmsJagannadha AvasaralaDiagnosis (Berlin, Germany)|November 17, 2025
Transatlantic confusion in MS diagnostic criteria: one patient, two continents, zero diagnosisJagannadha AvasaralaFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 16, 2025
Dark chocolate, heavy metals, and neurodevelopment in childrenJagannadha AvasaralaCNS Spectrums|January 4, 2019
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patientsJagannadha AvasaralaPageof 3